Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Variation in access to the liver transplant waiting list in the United States.

Mathur AK, Ashby VB, Fuller DS, Zhang M, Merion RM, Leichtman A, Kalbfleisch J.

Transplantation. 2014 Jul 15;98(1):94-9. doi: 10.1097/01.TP.0000443223.89831.85.

2.

Racial and ethnic disparities in access to liver transplantation.

Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM.

Liver Transpl. 2010 Sep;16(9):1033-40. doi: 10.1002/lt.22108.

3.

Outcomes after liver transplantation of patients with Indo-Asian ethnicity.

Rocha C, Perera MT, Roberts K, Bonney G, Gunson B, Nightingale P, Bramhall SR, Isaac J, Muiesan P, Mirza DF.

Transplantation. 2015 Apr;99(4):860-6. doi: 10.1097/TP.0000000000000411.

PMID:
25211517
4.

Disparities in liver transplantation before and after introduction of the MELD score.

Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ.

JAMA. 2008 Nov 26;300(20):2371-8. doi: 10.1001/jama.2008.720.

5.

Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.

Liver Transpl. 2012 Dec;18(12):1456-63. doi: 10.1002/lt.23548.

6.

End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.

Sharma P, Schaubel DE, Gong Q, Guidinger M, Merion RM.

Hepatology. 2012 Jan;55(1):192-8. doi: 10.1002/hep.24632. Erratum in: Hepatology. 2012 Apr;55(4):1311.

7.

Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.

Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.

Liver Transpl. 2011 Feb;17(2):129-36. doi: 10.1002/lt.22218.

8.

Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.

Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.

Transplant Proc. 2012 Oct;44(8):2283-5. doi: 10.1016/j.transproceed.2012.07.045.

PMID:
23026574
9.

Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.

Arce CM, Goldstein BA, Mitani AA, Lenihan CR, Winkelmayer WC.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2149-57. doi: 10.2215/CJN.01560213.

10.

The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil.

Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH.

Einstein (Sao Paulo). 2012 Jul-Sep;10(3):278-85. English, Portuguese.

11.

Sex-based disparities in liver transplant rates in the United States.

Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM.

Am J Transplant. 2011 Jul;11(7):1435-43. doi: 10.1111/j.1600-6143.2011.03498.x.

12.

Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry.

Schlansky B, Chen Y, Scott DL, Austin D, Naugler WE.

Liver Transpl. 2014 Sep;20(9):1045-56. doi: 10.1002/lt.23917.

13.

Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.

Kwong AJ, Lai JC, Dodge JL, Roberts JP.

Liver Transpl. 2015 Nov;21(11):1403-9. doi: 10.1002/lt.24307.

14.

Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians.

Volk ML, Choi H, Warren GJ, Sonnenday CJ, Marrero JA, Heisler M.

Am J Transplant. 2009 Sep;9(9):2113-8. doi: 10.1111/j.1600-6143.2009.02744.x.

15.

Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.

Urrunaga NH, Magder LS, Weir MR, Rockey DC, Mindikoglu AL.

Dig Dis Sci. 2016 Jan;61(1):309-16. doi: 10.1007/s10620-015-3870-y.

PMID:
26386861
16.

HCC patients suffer less from geographic differences in organ availability.

Schuetz C, Dong N, Smoot E, Elias N, Schoenfeld DA, Markmann JF, Yeh H.

Am J Transplant. 2013 Nov;13(11):2989-95. doi: 10.1111/ajt.12441.

17.

A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.

Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM.

Gastroenterology. 2011 Jun;140(7):1952-60. doi: 10.1053/j.gastro.2011.02.017.

18.

Serum sodium and survival benefit of liver transplantation.

Sharma P, Schaubel DE, Goodrich NP, Merion RM.

Liver Transpl. 2015 Mar;21(3):308-13. doi: 10.1002/lt.24063.

19.

Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.

Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW.

PLoS One. 2013;8(1):e51926. doi: 10.1371/journal.pone.0051926.

20.

Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.

Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y.

J Gastroenterol. 2014 Feb;49(2):324-31. doi: 10.1007/s00535-013-0782-5.

PMID:
23478939
Items per page

Supplemental Content

Support Center